Caesarea, Israel-based Mazor Robotics projects first quarter 2017 earnings of about $11.5 million, spurred by Mazor X sales as well as an increased number of procedures.
Here are five insights:
1. In Q1 2017, Mazor received six Mazor X purchase orders in the United States. Two of these purchases represented trade-in orders from customers who previously bought the Renaissance system.
2. On the international sale, Mazor received a purchase order for a Renaissance brain module upgrade.
3. In Q1 2016, Mazor saw $6.4 million in revenue and received five Renaissance purchase orders.
4. Mazor has sold 40 Mazor X systems since its launch in the second half of 2016.
5. The company will report its Q1 financial results in May.
More articles on devices:
MicroPort Orthopedics launches system to help TKR patients — 5 takeaways
Integra expands credit facility to include $700M term loan — 4 details
Cutting mortality risk by shining light on osteoporosis & vertebral compression fracture treatment